Literature DB >> 17512363

Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease.

Benjamin D Horne1, Nicola J Camp, Jeffrey L Anderson, Chrissa P Mower, Jessica L Clarke, Matthew J Kolek, John F Carlquist.   

Abstract

OBJECTIVES: The objective of this study was to identify associations of the cholesteryl ester transfer protein (CETP) gene with coronary artery disease (CAD) with tagging (t) single nucleotide polymorphisms (SNPs) chosen to optimally account for intra-genic variation.
BACKGROUND: The CETP gene plays a critical role in lipoprotein metabolism, but the common and well-studied TaqIB variant is inconsistently predictive of CAD.
METHODS: From a deoxyribonucleic acid bank of 10,020 individuals, nondiabetic nonsmoking patients (n = 4,811) with angiographically defined, clinically significant CAD (> or =70% stenosis) or normal coronaries were genotyped for 11 CETP tSNPs. Myocardial infarction (MI) and lipid levels were evaluated as secondary end points.
RESULTS: Analysis of single tSNPs, corrected for multiple comparisons (p < 0.00485), identified allele +1086A to be associated with CAD (p = 0.0034). Suggestive allelic and significant genotypic associations were found for -631AA (odds ratio [OR] = 3.95, p = 0.004 vs. CC) and +2389GA (OR = 1.21, p = 0.003 vs. GG). Haplotype analysis by linkage disequilibrium (LD) group revealed a CAD association for LD group B (p = 0.0025 across T+1086A, C+878T, C+408T) and near significance for LD group A (p = 0.013 across C-631A, MspI, G+2389A). A weak protective trend for TaqIB was eliminated by adjustment for other tSNPs, and haplotype analyses suggested that TaqIB was simply a marker for other tSNPs or haplotypes. No tSNP or haplotype associations with MI were found.
CONCLUSIONS: Multiple, less common SNPs and haplotype variants underlie CETP-related CAD risk, for which the common TaqIB variant is simply a poor marker. The occurrence of risk-related variants on separate haplotypes suggests genetic-risk complexity and allelic heterogeneity. (Database Registry of the Intermountain Heart Collaborative Study; http://clinicaltrials.gov/ct/show/NCT00406185?order=1; NCT00406185).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512363     DOI: 10.1016/j.jacc.2007.02.039

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Search for type 2 diabetes susceptibility genes on chromosomes 1q, 3q and 12q.

Authors:  F Takeuchi; Y Ochiai; M Serizawa; K Yanai; N Kuzuya; H Kajio; S Honjo; N Takeda; Y Kaburagi; K Yasuda; S Shirasawa; T Sasazuki; N Kato
Journal:  J Hum Genet       Date:  2008-02-08       Impact factor: 3.172

2.  Gene-environment interactions of CETP gene variation in a high cardiovascular risk Mediterranean population.

Authors:  Dolores Corella; Paula Carrasco; Montserrat Fitó; Miguel Angel Martínez-González; Jordi Salas-Salvadó; Fernando Arós; José Lapetra; Marisa Guillén; Carolina Ortega-Azorín; Julia Warnberg; Miquel Fiol; Valentina Ruiz-Gutierrez; Lluís Serra-Majem; J Alfredo Martínez; Emilio Ros; Ramón Estruch
Journal:  J Lipid Res       Date:  2010-06-25       Impact factor: 5.922

3.  Identification of genes contributing to cardiovascular disease in overweight and obese individuals from West Virginia.

Authors:  Yulia Dementieva; Todd L Green; Donald A Primerano; Liping Wei; James Denvir; Paulette Wehner; Sarah Dodson; Mark R Flood; Bonnie A Pollock; Melinda Huff; Contessa Hill; Robert Kreisberg; Amanda Francis; Katie Morrison; Holly Blackwood; Mary Davis; Huey Miin Lee; Stafford Warren
Journal:  W V Med J       Date:  2012 Jan-Feb

4.  Vitamin D receptor gene as a candidate gene for Parkinson disease.

Authors:  Megan W Butler; Amber Burt; Todd L Edwards; Stephan Zuchner; William K Scott; Eden R Martin; Jeffery M Vance; Liyong Wang
Journal:  Ann Hum Genet       Date:  2011-03       Impact factor: 1.670

5.  Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease.

Authors:  Jeffrey L Anderson; Benjamin D Horne; Nicola J Camp; Joseph B Muhlestein; Paul N Hopkins; Lisa A Cannon-Albright; Chrissa P Mower; James J Park; Jessica L Clarke; Zachary P Nicholas; Jason T McKinney; John F Carlquist
Journal:  Am Heart J       Date:  2010-08       Impact factor: 4.749

6.  The relationship between genetic variations of the cholesteryl ester transfer protein gene and coronary artery disease in Turkish subjects.

Authors:  Fuat Gundogdu; Yekta Gurlertop; Ibrahim Pirim; Serdar Sevimli; Hasan Dogan; Sakir Arslan; Hulya Aksoy; Sule Karakelloglu; Huseyin Senocak
Journal:  Eurasian J Med       Date:  2009-04

7.  Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease.

Authors:  Benjamin D Horne; John F Carlquist; Joseph B Muhlestein; Tami L Bair; Jeffrey L Anderson
Journal:  Circ Cardiovasc Genet       Date:  2008-12

8.  Validation study of genetic associations with coronary artery disease on chromosome 3q13-21 and potential effect modification by smoking.

Authors:  Benjamin D Horne; Elizabeth R Hauser; Liyong Wang; Joseph B Muhlestein; Jeffrey L Anderson; John F Carlquist; Svati H Shah; William E Kraus
Journal:  Ann Hum Genet       Date:  2009-08-25       Impact factor: 1.670

Review 9.  Creating a genetic risk score for coronary artery disease.

Authors:  Sonny Dandona; Robert Roberts
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

10.  SimHap GUI: an intuitive graphical user interface for genetic association analysis.

Authors:  Kim W Carter; Pamela A McCaskie; Lyle J Palmer
Journal:  BMC Bioinformatics       Date:  2008-12-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.